$1.14M In Fees Requested In Settlement Over Alleged Deceptive Pain Reliever Label
NEW YORK — Counsel representing the plaintiffs who reached a class settlement with CVS Pharmacy Inc. over claims that it misrepresented that its nonprescription lidocaine pain products contain “maximum strength” of...To view the full article, register now.
Already a subscriber? Click here to view full article